Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

SARS-CoV-2

ABSTRACT: Nanopore adaptive sampling with carrier DNA (NASCarD)

PROVIDER: PRJNA930601 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR23347156_1.fastq.gz	Fastqsanger.gz
	SRR23347157_1.fastq.gz	Fastqsanger.gz
	SRR23347158_1.fastq.gz	Fastqsanger.gz
	SRR23347159_1.fastq.gz	Fastqsanger.gz
	SRR23347160_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

Nanopore adaptive sampling with carrier DNA

Project description:Nanopore adaptive sampling with carrier DNA

| PRJEB59467 | ENA

Evaluation of adaptive sampling methods on Nanopore

Project description:Evaluation of adaptive sampling methods on Nanopore

| PRJEB73272 | ENA

Nanopore Adaptive Sampling for pneumococcal surveillance

Project description:Nanopore Adaptive Sampling for pneumococcal surveillance using serotyping

| PRJEB72455 | ENA

Structures from "Engineering Neutralizing SARS-CoV Antibodies to Bind SARS-CoV-2"

Project description: Not available

| S-BSST379 | biostudies-other

Plasmodium adaptive sampling

Project description:Assessment of Nanopore adaptive sampling for Plasmodium whole-genome sequencing

| PRJEB57715 | ENA

Altered Subgenomic RNA Abundance in SARS-CoV-2 B.1.1.7 Infections

Project description:SARS-CoV-2 lineage B.1.1.7 viruses are more transmissible, may lead to greater clinical severity, and result in modest reductions in antibody neutralization. Subgenomic RNA(sgRNA) is produced by discontinuous transcription of the SARS-CoV-2 genome. Applying our tool(periscope) to ARTIC Network Nanopore genomic sequencing data from 4400 SARS-CoV-2 positive clinical samples, we show that normalised sgRNA is significantly increased in B.1.1.7(alpha) infections(n=879). This increase is seen over the previous dominant circulating UK lineage, B.1.177(n=943), which is independent of genomic reads, E-gene cycle-threshold and days since symptom onset at sampling. A noncanonical sgRNA which could represent ORF9b is found in 98.4% of B.1.1.7 SARS-CoV-2 infections compared with only 13.8% of other lineages, with a 16-fold increase in median sgRNA abundance. We demonstrate that ORF9b protein levels are increased 6-fold in B.1.1.7 compared to a B lineage virus during in vitro culture. We hypothesise that this enhanced presence of ORF9b in B.1.1.7 viruses is a direct consequence of a triple nucleotide mutation in nucleocapsid(28280:GAT>CAT,D3L) creating a transcription regulatory-like sequence complementary to a region 3’ of the genomic leader. These findings provide a unique insight into the biology of B.1.1.7 and support monitoring of sgRNA profiles in sequence data to evaluate emerging potential variants of concern.

2021-11-26 | PXD029954 | Pride

Project description:Metagenomic surveillance for bacterial tick-borne pathogens using nanopore adaptive sampling

| PRJNA757915 | ENA

Microbial Community Standard

Project description:Nanopore Adaptive Sampling: Zymobiomics Microbial Community Standards Sequenoscope Tool Comparison Study

| PRJNA1051081 | ENA

Project description:Advancing targeted haplotyping in pharmacogenomics using Oxford Nanopore Technologies' adaptive sampling

| PRJNA1003794 | ENA

Project description:Nanopore adaptive sampling for metagenomic detection of human tick-borne pathogens

| PRJNA790938 | ENA